| AUCyber Limited (CYB) ORDINARY FULLY PAID |
Information Technology |
$18 |
Change in substantial holding from 5GN
|
14 Feb 2025 8:31AM |
$0.135 |
$0.087 |
fallen by
35.56%
|
|
| 5G Networks Limited (5GN) ORDINARY FULLY PAID |
Information Technology |
$39 |
Change in substantial holding for CYB
|
14 Feb 2025 8:31AM |
$0.155 |
$0.130 |
fallen by
16.13%
|
|
| AMP Limited (AMP) ORDINARY FULLY PAID |
Financials |
$4,266 |
AMP Sustainability Report
|
14 Feb 2025 8:30AM |
$1.750 |
$1.685 |
fallen by
3.71%
|
|
| AMP Limited (AMP) ORDINARY FULLY PAID |
Financials |
$4,266 |
Appendix 4G & 2024 Corporate Governance Statement
|
14 Feb 2025 8:30AM |
$1.750 |
$1.685 |
fallen by
3.71%
|
|
| AMP Limited (AMP) ORDINARY FULLY PAID |
Financials |
$4,266 |
AMP FY24 Data Pack
|
14 Feb 2025 8:30AM |
$1.750 |
$1.685 |
fallen by
3.71%
|
|
AMP - Price-sensitive ASX Announcement
Full Release
Key Points
- AMP Limited released the FY 24 Data Pack on 14 February 2025.
- The data pack includes financial summaries and performance metrics for multiple business units.
- It indicates a statutory profit attributable to shareholders based on Australian Accounting Standards.
- The financial information reflects a management view rather than a statutory view.
- The data pack is not an offer document and has not undergone a full due diligence process.
- Past performance is not a reliable indicator of future performance.
- All dollar values are in Australian dollars unless stated otherwise.
- The report includes information on discontinued operations and restates prior periods accordingly.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AMP Limited (AMP) ORDINARY FULLY PAID |
Financials |
$4,266 |
AMP FY24 Investor Presentation
|
14 Feb 2025 8:30AM |
$1.750 |
$1.685 |
fallen by
3.71%
|
|
AMP - Price-sensitive ASX Announcement
Full Release
Key Points
- Underlying NPAT increased by 15.1% to $236 million
- Total revenue down by 1.1% due to lower net interest income
- Controllable costs reduced by 6.1%
- Strong performance noted in Platforms and Superannuation & Investments
- Capital management program returned $1.1 billion to shareholders
- Full-year dividend increased to 3.0 cents per share
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AMP Limited (AMP) ORDINARY FULLY PAID |
Financials |
$4,266 |
AMP Announces FY24 Results
|
14 Feb 2025 8:30AM |
$1.750 |
$1.685 |
fallen by
3.71%
|
|
AMP - Price-sensitive ASX Announcement
Full Release
Key Points
- Underlying NPAT up 15.1% to $236 million
- Platforms underlying NPAT increased 18.9% to $107 million
- Superannuation & Investments underlying NPAT rose 26.4% to $67 million
- AMP Bank NPAT decreased 22.6% to $72 million
- New Zealand Wealth Management NPAT up 8.8% to $37 million
- Statutory NPAT of $150 million reflecting business simplification costs
- Controllable costs decreased by 6.1% to $648 million
- Completed the $1.1 billion capital return program
- Final dividend declared at 1.0 cent per share, totaling 3.0 cents for FY 24
- Successful launch of a new digital bank
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AMP Limited (AMP) ORDINARY FULLY PAID |
Financials |
$4,266 |
Dividend/Distribution - AMP
|
14 Feb 2025 8:30AM |
$1.750 |
$1.685 |
fallen by
3.71%
|
|
| AMP Limited (AMP) ORDINARY FULLY PAID |
Financials |
$4,266 |
Appendix 4E & 2024 Annual Report
|
14 Feb 2025 8:30AM |
$1.750 |
$1.685 |
fallen by
3.71%
|
|
AMP - Price-sensitive ASX Announcement
Full Release
Key Points
- Underlying NPAT increased by 15.1% to $236 million.
- Statutory NPAT of $150 million reflects a 43.4% decline due to loss on sale of Advice business.
- Transaction completed with Entireti and AZ NGA for AMP's Advice business.
- Focus on driving efficiencies and managing costs effectively.
- Final dividend declared at 1.0 cent per share, totaling 3.0 cents for FY 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PlaySide Studios Limited (PLY) ORDINARY FULLY PAID |
Communication Services |
$92 |
1HFY25 Results Webinar
|
14 Feb 2025 8:30AM |
$0.205 |
$0.225 |
risen by
9.76%
|
|
| FireFly Metals Ltd (FFM) ORDINARY FULLY PAID |
Materials |
$765 |
Half Yearly Report and Accounts
|
14 Feb 2025 8:29AM |
$1.020 |
$1.170 |
risen by
14.71%
|
|
| Maximus Resources Limited (MXR) ORDINARY FULLY PAID |
Materials |
$33 |
Change in substantial holding from AAR
|
14 Feb 2025 8:27AM |
$0.064 |
$0.077 |
risen by
20.31%
|
|
| Astral Resources NL (AAR) ORDINARY FULLY PAID |
Materials |
$234 |
Change in substantial holding for MXR
|
14 Feb 2025 8:27AM |
$0.140 |
$0.165 |
risen by
17.86%
|
|
| Astral Resources NL (AAR) ORDINARY FULLY PAID |
Materials |
$234 |
Retraction of Forecast Financial Information
|
14 Feb 2025 8:26AM |
$0.140 |
$0.165 |
risen by
17.86%
|
|
| Infini Resources Limited (I88) ORDINARY FULLY PAID |
Materials |
$6 |
Application for quotation of securities - I88
|
14 Feb 2025 8:25AM |
$0.535 |
$0.110 |
fallen by
79.44%
|
|
| GQG Partners Inc. (GQG) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Financials |
$6,561 |
Appendix 4G
|
14 Feb 2025 8:23AM |
$2.370 |
$2.220 |
fallen by
6.33%
|
|
| GQG Partners Inc. (GQG) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Financials |
$6,561 |
2024 Corporate Governance Statement
|
14 Feb 2025 8:23AM |
$2.370 |
$2.220 |
fallen by
6.33%
|
|
| GQG Partners Inc. (GQG) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Financials |
$6,561 |
2024 Full Year Results - Investor Presentation
|
14 Feb 2025 8:23AM |
$2.370 |
$2.220 |
fallen by
6.33%
|
|
GQG - Price-sensitive ASX Announcement
Full Release
Key Points
- GQG Partners reported net flows of $20.2 billion.
- Total funds under management increased by 26.9% to $153.0 billion.
- Net revenue rose by 46.9% to $760.4 million.
- Net operating income increased by 50.4% to $577.9 million.
- The board declared a final dividend of $0.0378 per share.
- All primary investment strategies outperformed their benchmarks.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| GQG Partners Inc. (GQG) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Financials |
$6,561 |
2024 Full Year Results - Media Release
|
14 Feb 2025 8:23AM |
$2.370 |
$2.220 |
fallen by
6.33%
|
|
GQG - Price-sensitive ASX Announcement
Full Release
Key Points
- Net flows of US$20.2 billion for the full year ended 2024
- Funds under management as at 31 December 2024 of US$153.0 billion
- 2024 Net revenue of US$760.4 million, an increase of 46.9% from 2023
- 2024 Net operating income of US$577.9 million, an increase of 50.4% from 2023
- Diluted earnings per share increased 52.3% from US$0.10 in 2023 to US$0.15 in 2024
- Board declares 4Q 2024 final dividend of US$0.0378 per share
- Expansion of the dividend payout ratio to 50% - 95% of distributable earnings approved
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| GQG Partners Inc. (GQG) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Financials |
$6,561 |
Dividend/Distribution - GQG
|
14 Feb 2025 8:23AM |
$2.370 |
$2.220 |
fallen by
6.33%
|
|
| GQG Partners Inc. (GQG) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Financials |
$6,561 |
Appendix 4E and 2024 Annual Report
|
14 Feb 2025 8:23AM |
$2.370 |
$2.220 |
fallen by
6.33%
|
|
GQG - Price-sensitive ASX Announcement
Full Release
Key Points
- GQG Partners Inc. reported a 26.9% increase in total FUM to $153 billion by the end of 2024.
- Net revenue growth was 46.9%, totaling $760.4 million, with management fees making up 96.8% of revenue.
- All four primary investment strategies have consistently outperformed their respective benchmarks.
- GQG launched the Private Capital Solutions business and acquired interests in private equity investments.
- The company ranked first in net flows in the Australian Global Large Growth Category and second in Emerging Markets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$222 |
Financial Report Form 8-K dated 13 February 2025
|
14 Feb 2025 8:23AM |
$2.760 |
$1.680 |
fallen by
39.13%
|
|
AVH - Price-sensitive ASX Announcement
Full Release
Key Points
- Fourth quarter commercial revenue of $18.4 million, up 30% year-over-year
- Full-year commercial revenue reached $64.0 million, a 29% increase
- Gross profit margin for Q4 was 87.6%
- FDA granted 510(k) clearance for Cohealyx™ on December 19, 2024
- FDA approved RECELL GO® mini on December 23, 2024
- Amended credit agreement with OrbiMed on February 13, 2025
- Projected 2025 commercial revenue expected between $100 to $106 million
- Aiming for GAAP profitability by Q4 2025
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$222 |
AVITA Medical Q4 & FY 2024 Earnings Presentation
|
14 Feb 2025 8:23AM |
$2.760 |
$1.680 |
fallen by
39.13%
|
|
AVH - Price-sensitive ASX Announcement
Full Release
Key Points
- AVITA Medical aims to be a leader in therapeutic acute wound care.
- RECELL facilitates quick wound healing and repigmentation.
- The company focuses on solutions for traumatic injuries and surgical repairs.
- Financial projections indicate a potential revenue growth in the burn treatment market.
- AVITA Medical's technologies are designed to enhance patient recovery outcomes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$222 |
AVITA Medical Reports Q4 and FY2024 Financial Results
|
14 Feb 2025 8:22AM |
$2.760 |
$1.680 |
fallen by
39.13%
|
|
AVH - Price-sensitive ASX Announcement
Full Release
Key Points
- Commercial revenue in Q4 2024 increased by approximately 30% to $18.4 million.
- Full-year 2024 commercial revenue reached $64.0 million, up 29% from 2023.
- Gross profit margin was 87.6% in Q4 2024 and 85.8% for the entire year.
- FDA granted approvals for RECELL GO mini and Cohealyx in December 2024.
- Net loss for Q4 2024 was $11.6 million, compared to a net loss of $7.1 million in Q4 2023.
- AVITA projects full-year 2025 commercial revenue of $100 to $106 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| FleetPartners Group Limited (FPR) ORDINARY FULLY PAID |
Financials |
$690 |
Update - Notification of buy-back - FPR
|
14 Feb 2025 8:22AM |
$2.640 |
$3.110 |
risen by
17.80%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
